目的:探讨国产注射用头孢西丁钠(海西丁)治疗感染性疾病的疗效。方法:治疗组24例采用海西丁,轻度感染者2 g.次-1,2次.d-1,疗程5~14 d;中、重度者3 g.次-1,2次.d-1,疗程5~14 d。对照组20例采用进口注射用头孢西丁钠(美福仙),用法同治疗组。疗效分痊愈、显效、进步、无效4级,以痊愈加显效为有效。结果:治疗组有效率87.5(21/24),对照组为80%(16/20),两组比较,χ2=0.458,P>0.05。治疗组细菌全部转阴,对照组有3例未转阴,且全为D肠球等。结论:海西丁与美福仙的疗效无差异,且海西丁抗菌谱更广一点。

AIM: To evaluate the efficacy and safety of lomefloxacin injection in the treatment of acute bacterial infections. METHODS: A total of 190 patients (160 patients in a randomized trial, 30 patients in an open trial) were divided into 2 groups. One hundred and ten patients (M 54,F 56; age 54 a± s 11 a) in treatment group received 200-400 mg,iv,qd for 7-10 d. Eighty patients (M 45,F 35; age 53 a±10 a) in control group received ciprofloxacin 200-400 mg,iv,bid, for 7-10 d. RESULTS: The effective rate and the bacterial clearance rate of the treatment group were 86% and 81% respectively, and that of the control group were 80% and 73% respectively. No significant difference was found between the 2 groups ( P 0.05). The adverse reaction of lomefloxacin was 4%. CONCLUSION: Lomefloxacin is the effective and safe antibacterial in the treatment of bacterial infections.

近20年来Ⅱ型糖尿病的患病率在我国逐年增高,并有进一步上升趋势,其并发的低血糖昏迷也明显增多.我院急诊科1991～1997年收治30例糖尿病低血糖昏迷患者,现分析总结如下.

酮症酸中毒是糖尿病常见的严重急性并发症,多继发于各种其他严重疾病,并易被原发病表现掩盖而误诊、漏诊.我院急诊科1993～1998年共收治老年糖尿病酮症酸中毒22例,本文重点讨论老年糖尿病酮症酸中毒的治疗特点和预后.